Neumora Therapeutics (NasdaqGS:NMRA) 2026 Conference Transcript

Neumora Therapeutics (NasdaqGS:NMRA) 2026 Conference February 11, 2026 04:00 PM ET Company ParticipantsHelen Rubinstein - VP of Investor Relations and Corporate CommunicationsJosh Pinto - PresidentNick Brandon - Chief Scientific OfficerConference Call ParticipantsDalma Khayati - Biotechnology Research AnalystYatin Suneja - Biotechnology Research AnalystYatin SunejaGood afternoon, everyone. Welcome to Guggenheim Emerging Outlook Biotech Summit 2026. It is my pleasure to welcome our next presenting company, N ...